PhaseBio Pharmaceuticals Inc
PHASDelisted Dec 21, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001169245
PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.
Holders of 5% or more of PHAS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of PhaseBio Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of PhaseBio Pharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on PhaseBio Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Avidity Partners Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2022 | New Enterprise Associates 13 LP | 13D/AOld format | – | – | – | SEC |
| Jul 19, 2022 | MAI Capital Management | 13G/AOld format | – | – | – | SEC |
| Feb 15, 2022 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Rosalind Advisors, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Avidity Partners Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Wellington Management Group LLP | 13GOld format | – | – | – | SEC |
| Feb 1, 20222:42 PM ET | Johnson & Johnson | 13G/AOld format | – | – | – | SEC |
| Nov 10, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Aug 10, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| May 19, 2021 | Rosalind Advisors, Inc. | 13GOld format | – | New | – | SEC |
| Mar 24, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Mar 22, 2021 | Avidity Partners Management LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Jan 11, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell PhaseBio Pharmaceuticals Inc shares.
No Form 144 notices for PhaseBio Pharmaceuticals Inc are on file.